TARA HARDINGE: Open Payments
NPI 1285128678 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,312 in 134 payments from 16 companies in 2025. Trend: 2023 $828 · 2024 $2,999 · 2025 $2,312
Food & beverage: $2,312
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $404 |
| Organon LLC | 6 | $259 |
| Incyte Corporation | 14 | $244 |
| GENZYME CORPORATION | 12 | $236 |
| Arcutis Biotherapeutics, Inc. | 10 | $204 |
| Lilly USA, LLC | 12 | $183 |
| Janssen Biotech, Inc. | 14 | $160 |
| Galderma Laboratories, L.P. | 8 | $146 |
| UCB, Inc. | 7 | $142 |
| LEO Pharma Inc. | 3 | $128 |
Products named: DUPIXENT, OPZELURA, SKYRIZI, Zoryve, RINVOQ, TALTZ, VTAMA, TREMFYA.
Industry payments across OR — which companies pay providers there.
